• Correlate Energy, a publicly traded distributed energy solutions company, has announced one addition to its C-suite team and two additions to its board of directors
• Johan Themaat will serve as the company’s new CFO, while Dr. Christine Gulbranson and Alina Zagaytova will serve on the board of directors
• Correlate’s management is confident that these appointments will play a pivotal role in the company’s continued success, as well as its commitment to sustainable energy solutions
• It is also confident that they will help assert the company’s position as a leader in the industry, even as it works toward providing clean energy solutions

Correlate Energy (OTCQB: CIPI), a publicly traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation, has announced notable additions to its c-suite team, as well as its board of directors. This follows the successful close of the 2023 calendar year and the commencement of what is set to be the company’s biggest year yet. Its management is confident that these appointments will play a pivotal role in Correlate’s continued success and its commitment to sustainable energy solutions (https://ibn.fm/q6mGT).

Johan Themaat will serve as Correlate’s new CFO. He will lend his years of experience, having held key positions and executed integral roles at prominent companies that include, but are not limited to, Mission Energy, NGL Energy Partners, and RBS, among others. Throughout his professional career, Themaat has demonstrated his expertise in guiding companies through strategic financial incentives, fetes that make him such a valuable addition to Correlate’s leadership.

Correlate also appointed Dr. Christine Gulbranson and Alina Zagaytova to its board of directors, additions that its management is confident will contribute to the strategic vision and growth of the company. Dr. Christine, the Founder of Nova Global Ventures, will lend her knowledge and expertise on AI and disruptive technology while also providing guidance and insight into strategic partnerships, AI-powered consumer technology, and commerce. This is further compounded by her commitment to innovation and her overall business acumen that has seen her oversee a $100 billion + technology investment portfolio, a $37 billion operations budget, and  $1 billion + in sales, having served as a Chief Innovation Officer for the University of California System.

Ms. Alina Zagaytova will also lend her expertise in renewable energy, having served on the boards of two clean energy companies – Clean Energy Collective, LLC and Younicos AG. She will also offer guidance on legal matters, given her background as a legal and corporate strategist with an impressive track record of closing over 50 transactions. In addition, her impeccable leadership skills, as evidenced by her recent role as General Counsel, Corporate Secretary, and Chief Compliance Officer of Redwood Materials, Inc., a lithium-ion battery materials company, will also be quite valuable at Correlate.

Correlate’s management is confident that these appointments will be integral to the company’s success going forward. It is also confident that the appointments will help assert the company’s position as a leader in the industry, even as it seeks to finance, develop, and profitably sell localized clean energy solutions and microgrids to industrial, commercial, and residential customers.

For more information, visit the company’s website at www.Correlate.Energy, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.correlate.energy/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.correlate.energy/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Lexaria, a global specialist in drug delivery platforms, just announced the final results from its recently completed human Pilot Study #1 on the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of GLP-1 drug, semaglutide
• The results showed improved delivery of semaglutide to the bloodstream, with the drug showing approximately 44% higher levels than the control 24 hours after ingestion of a single dose
• DehydraTECH GLP-1 processed semaglutide also proved to be better tolerated than the control, with the latter resulting in some cases of moderate nausea and diarrhea
• This milestone brings Lexaria closer to tapping into the diabetes and weight loss treatment market and sets the company up for what is expected to be its best year

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the final results from its recently completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). The drug is approved by the Food and Drug Administration (“FDA”), given its role in promoting insulin production in the body, which ultimately reduces blood glucose (https://ibn.fm/UGKtr).

Most notable from its pilot study was the improved delivery of semaglutide to the bloodstream, which significantly improved blood sugar control. For one, in just 20 minutes after oral administration, the DehydraTECH GLP-1 blood semaglutide level was about 261% higher than that of the Control, a statistic that reflected the technology’s ability to deliver drugs into the bloodstream faster. In addition, 24 hours after the ingestion of a single dose, the DehydraTECH GLP-1 blood semaglutide levels were approximately 44% higher than the Control levels.

The Rybelsus control witnessed a large increase in blood-glucose levels after eating a standardized meal at the 240-minute mark and a standardized snack at the 360-minute mark. But the DehydraTECH processed Rybelsus continued to reduce blood glucose even after eating. In addition, even as long as 24 hours after dose administration, Lexaria’s DehydraTECH GLP-1 showed a 5.01% reduction in blood glucose level relative to baseline, an indicator of greater efficacy in achieving blood glucose reduction, and helping attenuate the postprandial spikes in blood glucose experienced in the control group.

DehydraTECH GLP-1 processed semaglutide also proved better tolerated than the Rybelsus tablets, with the latter resulting in instances of moderate nausea and moderate diarrhea.

Lexaria first announced its intention to explore DehydraTECH’s effectiveness on GLP-1 drugs in September 2023. From the beginning, the goal was to achieve superior pharmacokinetic (“PK”) performance with the technology with reduced side effects and enhanced health benefits. With the just-released final results, Lexaria has achieved these objectives and more, ultimately setting itself up for additional human and animal studies in the 2024 calendar year.

This milestone brings Lexaria closer to tapping into the diabetes treatment market, valued at $92.97 billion in 2023 and projected to reach $118.77 billion by 2028 (https://ibn.fm/lsAji). It also marks an excellent start to the new year 2024, propping the company up for what will be its best year yet. Lexaria is already preparing for other human and animal studies to continue, details of which will be shared in the coming weeks.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

In a significant development for the neurological disorder community, PaxMedica (NASDAQ: PXMD) has released an insightful video detailing the outcomes of its Phase 2 study on Autism Spectrum Disorder (“ASD”), initially published in the Annals of General Psychiatry. This pivotal video highlights the research led by Chief Medical Officer Dr. David Hough and a team of ASD experts, and the potential of low-dose suramin intravenous infusions as a breakthrough treatment for ASD.

The study, a comprehensive 14-week randomized, double-blind, placebo-controlled trial, enrolled 52 boys aged 4–15 years with moderate to severe ASD. Focused on evaluating the efficacy and safety of suramin intravenous infusions, the study’s 10 mg/kg suramin arm displayed promising results in improving core symptoms of ASD, showcasing statistically significant improvements in the Clinical Global Impressions—Improvement (CGI-I) scale compared to the placebo group.

The study, registered with clinicaltrials.gov, represents a crucial advancement in exploring treatment options for ASD. PaxMedica’s unwavering commitment to pioneering research in neurological disorders is highlighted in the video release, demonstrating their dedication to enhancing the quality of life for individuals living with ASD.

The enlightening video can be viewed at https://ibn.fm/qKcGP, and the complete article is available for download at https://ibn.fm/Pc5ve.

For more information, visit the company’s website at www.PaxMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

• Ucore, a company engaged in the exploration for and separation and scalable production of REEs in Canada and the US, views China’s recent ban on the export of technology to produce rare earth permanent magnets as an opportunity
• Through this ban, the company looks to grow and assert its dominance in the sector, all while doing away with dependence on China
• This is made possible by its RapidSX(TM) technology, which it has been slowly perfecting
• It is also made possible by its  Demonstration Program, along with its Louisianna facility that sets it on track to separating friendly REEs and OEMs by 2025

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), engaged in the exploration for and separation and scalable production of rare earth elements (“REEs”) in Canada and the U.S., is looking to double down on its unique method of separation and refining of rare earth elements, an approach that it is confident will assert its market dominance, and stamp its position as an industry leader. This comes in the wake of China announcing a ban on the export of technology to produce rare earth permanent magnets, along with the ban on technology associated with the separation of REEs in what experts in the field have termed as an “REE race” (https://ibn.fm/ehEYY).

On December 21, 2023, China announced that it had banned all exports of technology to produce rare earth permanent magnets, citing national security concerns. It also confirmed the existing ban on technology associated with separating REEs. This followed the introduction of export permits for chipmaking materials – gallium and germanium – back in August, followed by similar requirements for other types of graphite in December 2023. The move was considered a wake-up call for the West and their dependence on China for the rare earth’s supply.

“This should be a clarion call that dependence on China in any part of the value chain is not sustainable,” noted Nathan Picarsic, the co-founder of Horizon Advisory, a geopolitical consulting firm.

Ucore views this as an opportunity to grow and assert its dominance in the sector. Its management has referred to these events as “remarkable,” coming just in time given its recent commencement of the U.S. Department of Defense (“DoD”) Demonstration Program.

“Ucore’s focus on the separation and refining of these critical materials is of increasing strategic importance to the burgeoning North American rare earth supply chain,” noted Pat Ryan, Ucore’s Chairman and CEO.

“Our recently commenced US DoD Demonstration Program could not come at a more important time,” he added (https://ibn.fm/P1XBU).

Ucore has been committed to and vocal about developing its technology and weakening China’s mineral dominance using its RapidSX(TM) technology. It is slowly perfecting and ultimately commercializing the separation and purification of critical metals in a significant move that would slash reliance on China, which currently controls 90% of refined rare earth output. Its focus over the years has been on perfecting its process, all while re-establishing a North American supply chain.

“Our goal is to re-establish a North American rare earths supply chain,” noted Michael Schrider, Ucore’s COO (https://ibn.fm/edOli).

The recent developments in China point to how integral Ucore’s initiatives are, not just for North America but for the West as a whole. Having made incredible headway over the years, it is also a beacon of hope and a trailblazer in an industry dominated by Chinese players. Already, the company is on track to commercially separate friendly sources of REEs and OEMs with rare earth oxides (“REOs”) required to produce rare earth magnets by 2025. This will be made possible by its Demonstration Program and Alexandria, Louisiana facility, with an estimated throughput of 7,500 tons of total rare earth oxides per annum.

For more information, visit the company’s website at www.Ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

• Agencies and nonprofits serving domestic violence victims are seeing an increase in victim numbers
• With typical pressures on funding, governments require a cost-effective solution that can help keep victims safe while maintaining supervision of domestic violence offenders under court-ordered supervision
• SuperCom’s PureSecurity electronic monitoring suite offers governments a cost-effective solution for monitoring offenders through GPS monitoring, home detention, domestic violence prevention, and more

SuperCom (NASDAQ: SPCB), a provider of secured solutions for the e-government, IoT, and cybersecurity sector, is on a mission to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.  The company’s technology comes at a time when there is an increased need for cost-effective monitoring solutions for dealing with various offenders’ populations such as domestic violence offenders, prison inmates, and more.

In the case of the United States, victims of domestic violence turn to local agencies and nonprofits for services and support. Many of these establishments utilize federal funding to run their operations – primarily funding established through the Victims of Crime Act (“VOCA”). Funding through VOCA has decreased over the last five years, and these agencies and nonprofits are often forced to downsize their operations despite the growing number of domestic violence victims. This further pressures the government to implement the most cost-effective solutions for dealing with offenders and keeping victims safe.

Berg Insight reported that the total market for the electronic monitoring of offenders in the United States, Europe, and Latin America, totaled $1.2 billion in 2021. It is expected to grow at a CAGR of 10.8%, resulting in an estimated value of $2.1 billion by 2026. The market’s growth can be attributed to the growing adoption of GPS-based and smartphone-based solutions. The evolution of technology is also a contributing factor, with modern data analytics tools making it increasingly possible to identify offender behavior patterns and possibly predict future electronic monitoring violations or offenses (https://ibn.fm/3GcyQ).

SuperCom’s proprietary PureSecurity suite is an all-in-one, field-proven offender monitoring system, with services such as GPS monitoring, home detention, domestic violence prevention, and more. The suite is specifically tailored to meet each client’s needs. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – geared toward optimizing decision-making and operational efficiency.

SuperCom’s technology offers competitive advantages, including:

• Long Battery Life (No Tag Charging Required)
• Ultra Lightweight Form Factor
• Next-Gen Location Tech
• Protection of Domestic Violence Victims
• And More

SuperCom’s PureSecurity suite for electronic monitoring under court-ordered programs includes the company’s GPS enrollee digital tracking platform PureTrack, the PureTag wearable RF bracelet, the PureOne one-piece tracking device, and the home-based PureCom station. The solution makes it more affordable for governments to track domestic violence offenders, reducing the number of incarcerations, reducing costs, and maintaining their dedication to protecting the victims of acts of domestic violence.

Ordan Trabelsi, SuperCom’s President and CEO, said in a November 14, 2023 press release that the company was uniquely positioned to capitalize on the increasing global demand for secured electronic monitoring solutions is strategically investing in the continuous improvement of its offerings, extending its reach into new markets, which is already yielding promising results in the U.S. and other regions (https://ibn.fm/Dagog). “Our focus remains on driving innovation, enhancing operational efficiencies, and delivering exceptional value to our customers and stakeholders,” Trabelsi said. “We are confident that our strategic decisions will further propel us towards achieving our long-term objectives and securing SuperCom’s position as a leader in the industry.”

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

• $25 million paid in capital
• First-to-market, innovative detection technology – hardware + SaaS
• Traction established and clear expansion path in three mega markets
• Integration, licensing and white labelling could accelerate trajectory
• Robust IP protection

SOBRsafe (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck(TM) for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure(TM)) and licensing or white labeling.

The company is headquartered in the Denver (“CO”) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe(TM)

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe(TM) platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck(TM)

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure(TM)

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

For more information, visit the company’s website at www.SOBRsafe.com.

NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/SOBR

• Digital engagement company Electronic Servitor Publication Network has assembled a strong portfolio of technology by its recent merger with Pointward, an IP holding company, and acquisition of key assets from PhiTech Management LLC, an engagement technology company
• XESP’s acquisitions greatly enhance the company’s workflows and represent significant value for channel partners and customers
• The company’s Digital Engagement Engine(TM) combines automation, unique data management, and a modern workflow built on a microservices architecture, to achieve significantly greater reach and lift for clients looking to engage with target markets more effectively

Electronic Servitor Publication Network (OTCQB: XESP) is a digital engagement company, using advanced technologies to ensure that client companies drive growth with real connections to target markets. The company recently announced the finalization of its merger with Pointward Inc., a Delaware intellectual property holding company, for its channel activation and customer engagement assets. Along with XESP’s purchase of advanced technologies from PhiTech Management LLC, the company has assembled a powerful portfolio of customer engagement capabilities, positioning XESP as a market leader in the digital engagement space (https://ibn.fm/v9ljc).

In the case of Pointward, their intellectual property includes proven models, methods, protocols, tools, and technologies, designed to identify audience segments and engage each segment with customized content to create relevant, one-to-one digital relationship pathways in both highly regulated and unregulated markets. XESP has finalized operational integration plans and will fully integrate the technologies and tools into its existing technology stack, the Digital Engagement Engine(TM).

“We are pleased that we are now able to utilize Pointward’s impressive portfolio of intellectual property to enhance our managed service product and to gain the capability and expertise to serve both highly regulated and unregulated markets,” said Thomas Spruce, XESP COO and sole director.

XESP’s Digital Engagement Engine(TM) combines automation, unique data management, and a modern workflow built on a microservices architecture to achieve greater reach and lift. Using sophisticated data analysis and smart technology, the Digital Engagement Engine(TM) allows companies to control their content completely while creating meaningful relationships with new customers and revenue streams. The Digital Engagement Engine(TM) is not just another marketing or technology tool; it’s a way to develop real connections with target markets.

“As part of our continued evolution and vision of digital transformation leadership, the deep IP from Pointward will be a major enhancement to our workflows and create immediate value for our channel partners and customers alike,” said Peter Hager, CEO of XESP.

XESP’s Channel Partner program allows partnered digital and traditional agencies to offer their customers the benefits of XESP’s Digital Engagement Engine(TM) as a service extension. This approach gives Channel Partner customers additional growth-focused services from their current trusted point of contact while de-risking investment in new technologies and staff.  The Channel Partner program creates additional revenue sources for both XESP and Channel Partners.

The global customer engagement solutions market was valued at $19.3 billion in 2022. It is projected to reach $32.2 billion by 2027, growing at a CAGR of 10.8%. The market is expected to gain momentum as more companies adopt customer engagement solutions to reduce customer churn rates. The largest cause of churn is the lack of customer engagement and experience – more companies are looking to increase the customer experience and how it translates to their brand’s messaging (https://ibn.fm/fxoAZ).

The company markets its “Growth as a Service” offerings in such a way as to make the client’s implementation nearly effortless, with the XESP team completely managing the operational solution. The business model was designed to allow clients to focus on their brands, core product offerings, and content creation, while XESP manages the technology and outcome.

For more information, visit the company’s website at www.XESPN.com.

NOTE TO INVESTORS: The latest news and updates relating to XESP are available in the company’s newsroom at https://ibn.fm/XESP

• Tokenized securities that tie digital coins to real world assets are gaining popularity as a safer outlet for investors experimenting with playing in the emerging blockchain-enabled marketplace
• Many leading investment asset managers are predicting tokenization will become the future of the marketplace and “the next generation” of securities investing
• Diamond Lake Minerals is helping investors who are interested in the emerging market but wary of the unknowns to bridge the divide and investigate digital securities through investment in more traditional assets that are imbued with SEC-registered security token offerings (“STOs”)
• STOs provide investors with the relative security of a government-regulated offering, and a growing number of governments worldwide are following suit

The potential of high returns on investment continues to create a draw for digital assets in the emerging blockchain-enabled marketplace, even though most investors aren’t experts on blockchain technology. Many find themselves continually challenged to evaluate the competing claims of tokenized companies and the benefits of the varied specialized purposes the tokens may serve.

World-leading asset manager BlackRock ($7 trillion under management) CEO Larry Fink made news about the staying power of digital assets in November when he said, “The next generation for markets, the next generation for securities, will be tokenization of securities,” at a New York Times DealBook event (https://ibn.fm/D3DGT).

Other serious financial market players also have stated tokens are “a much bigger story than cryptocurrencies” and are central to the future of finance, sparking a drive to update institutional strategies. Key to the blockchain marketplace is its emphasis on “transparency” in non-fiat transactions (despite the exception of the more controversial “privacy token” sector), and a recent Forbes opinion piece argued that transactions can be transparent without revealing all user data (https://ibn.fm/aeXaF).

Multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) has experienced rapid growth during the past reporting semester as it has reinvented itself with an aim of becoming a leading player in this evolving security token space.

To avoid the pitfalls of some digital tokens that have become the target of U.S. Securities and Exchange Commission (“SEC”) enforcement actions in recent months, DLMI is “solely focused on a regulated environment,” Diamond Lake CEO Brian J. Esposito said during a Dec. 20 interview with financial media outlet Benzinga (https://ibn.fm/RXQ0E).

Its effort to bridge the divide between traditional, stock-and-bond-based wealth and digital asset finance has resulted in a model that involves building a vertically integrated ecosystem of industry-agnostic holdings with a broad market reach, and then creating a U.S. SEC-registered security token offering for each of them. 

Investors interested in music and other aspects of the entertainment industry, media, healthcare, real estate and numerous other sectors may find a prospect that appeals to them amid DLMI’s holdings, and can then use the STO in their investment as a seamless, uncomplicated means of sticking a toe into the tokenized security pool to test the waters.

Diamond Lake’s vertically integrated ecosystem will help them “share resources, support one another, and ensure that if there’s a downside in one industry or segment, that we have a diversified model to help keep everything afloat and everything growing,” Esposito said during a November interview (https://ibn.fm/rqOni).

Japan, the first country to impose an outright ban on privacy tokens that prioritize anonymity over transparency (https://ibn.fm/oDCVf), has inversely signaled its faith in the potential of tokenized securities as a means of allowing investors to move reserves from “near-zero interest bank deposits” to “riskier, higher return investments,” launching its first digital securities trading on Christmas Day (https://ibn.fm/CsA9e).

The country’s move is emblematic of the impetus digital assets are gaining in the marketplace.

“I love working in the regulated environment because it’s a place that helps ensure protecting people,” Esposito said.

For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

In addition, for information on the company’s security token SEC regulated exchange partner INX, and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

Industry experts, entrepreneurs, investors, and innovators from all areas of the mobile industry are invited to attend the MGS 24 Las Vegas being held on February 15-16, 2023, in Las Vegas. This transformative event offers the perfect blend of advanced mobile and Web3 growth technology. With a special focus on blockchain and artificial intelligence (“AI”), the summit will bring together visionaries and thought leaders to share insightful ideas about the future of the mobile industry.

MGS 24 is designed to promote unmatched innovation at the intersection of mobile and web3 technologies. The summit will serve as a catalyst for exploring new frontiers for user experience and engagement. Featuring unmatched networking opportunities, the summit provides attendees with a unique opportunity to meet top industry leaders and attend knowledgeable panel discussions and keynote sessions.

Focus on Blockchain and AI Technology

MGS 24 is driven by AI innovation where experts will cover their unique strategies and case studies, geared to improving mobile performance, user personalization, and predictive analytics. The theme of the summit will revolve around leveraging the potential of Web3 technologies and mobile growth. It’s a great opportunity for participants to attend meticulously curated workshops led by industry experts.

The much-awaited MGS 24 will provide an extensive understanding of the latest technologies, trends, and tools driving mobile growth in the Web3 age. This one-of-a-kind networking gala enables technology enthusiasts to connect with potential collaborators and like-minded professionals. Visionaries will share their insights into AI for scaling growth, decentralized applications (DApps), and the blockchain-powered future of finance and mobile gaming.

To learn more, please visit https://ibn.fm/XhP89

Professionals and executives specializing in real world evidence, HEOR, market access, and medical affairs are all invited to attend DGE’s 3rd Real World Evidence & Market Access being held in Philadelphia on February 26-27, 2024. This event is organized by DGE, a life sciences leader in B2B conferences offering in-depth events primed with multiple networking opportunities amongst the pharma, biotech, healthcare, and medical fields.

This event features keynotes, discussions, and interactive sessions about the importance and value of RWE. Real world evidence shapes healthcare decisions by offering insights into the effectiveness, safety, and cost-effectiveness of treatments. This conference offers a phenomenal platform for biopharma companies to gain insights into the various aspects of RWE utilization including discussions on the role of RWE in supporting regulatory and HTA decisions, how RWE can be utilized in clinical trials, and the impact that AI is having on processing and interpreting RWE data.

Industry leading speakers from Astrazeneca, Merck, Pfizer, Agenus, and Chiesi will come together to discuss topics such as balancing the cost and value of pharmaceutical products, optimizing treatment precision using AI, and investigating the ethical and legal considerations concerning RWE data analysis.

This event features topics such as:

• Understanding how regulatory decision-making can be enhanced with RWE to improve safety, efficacy, and patient outcomes
• Investigating the significance of RWE in single-arm clinical trials and how RWD can contribute to evidence generation in smaller patient populations
• Studying the role RWE plays in shaping drug reimbursement decisions
• Engaging in talks about assessing the cost and value of a product. Does the value of the drug justify its cost?
• Discussing the future of how RWE and AI will work together for many things including treatment precision and RWD analysis

Learn about RWE’s role in clinical trials, emerging AI trends, and new governmental regulations associated with RWE. The event forum will witness industry experts from AbbVie, Blueprint Medicines, Biogen, and many more who will share their expertise on RWE so your team is prepared to enter this new age of data collection and analysis.

To know more, please visit https://ibn.fm/8NcxG.